EVG.L Gross Margin

The Gross Margin of Evgen Pharma PLC (EVG.L) is -1151.58%.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

EVG.L Gross Margin - Historical Value

Date	Value
2023-03-31	-1151.58%
2022-03-31	-1647.42%

EVG.L Gross Margin - Peers Comparison

Ticker	Name	Value
ALPAT.PA	Plant Advanced Technologies PAT SA	128.03%
PROMO.ST	Promore Pharma AB	-124472.22%
GEN.WA	Genomed SA	44.96%
IDOGEN.ST	Idogen AB	7775.20%
MTPH.L	Midatech Pharma PLC	94.91%
SCS.WA	Stem Cells Spin SA	86.16%
AEGIR.ST	Aegirbio AB	47.83%
BCYC	Bicycle Therapeutics PLC	7775.20%
CNTA	Centessa Pharmaceuticals PLC	7775.20%
VAL.L	ValiRx PLC	85.00%
MVIR B.ST	Medivir AB	-147045.00%
ADAP	Adaptimmune Therapeutics PLC	99.96%
LIDDS.ST	Lidds AB	-1102.81%
GNS.L	Genus PLC	36.68%
TOL.ST	Toleranzia AB	1842.86%
ABNX.PA	Abionyx Pharma SA	18.35%
ACTI.ST	Active Biotech AB publ	100.00%
COMBI.ST	Combigene AB	-14.34%
RDG.WA	Read Gene SA	93.23%
SLN.L	Silence Therapeutics PLC	3133.78%
XINT.ST	Xintela AB	100.00%
ALLR.ST	Allarity Therapeutics A/S	-175.91%
GUARD.ST	Guard Therapeutics International AB (publ)	100.00%
MYOV	Myovant Sciences Ltd	77.68%
CMPS	Compass Pathways PLC	7775.20%
OXB.L	Oxford Biomedica PLC	41.17%
SENZA.ST	SenzaGen AB	66.89%
GV.PA	Genomic Vision SA	-165.01%
IMMU.ST	Mendus AB (publ)	7775.20%
ISR.ST	ISR Immune System Regulation Holding AB (publ)	-45046.17%
SPRINT.ST	Sprint Bioscience AB	56.83%
ABC.L	Abcam PLC	71.12%
ALZ.ST	Alzinova AB	-32846.67%
ALNEV.PA	Neovacs SA	5.49%
ALPRE.PA	Predilife SA	97.25%
IMCR	Immunocore Holdings PLC	99.12%